Cargando…

Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease

BACKGROUND: Limited information is available about the proportion of patients with degenerative lumbar spinal disease (DLSD) who have gastrointestinal (GI) and cardiovascular (CV) risk factors. Many DLSD patients are prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) that are known to carry ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jae-Ho, Lee, Byoung-Ho, Eum, Kwang-Sik, Suk, Kyoung-Soo, Park, Jin-Oh, Kim, Hak-Sun, Lee, Hwan-Mo, Moon, Seong-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Orthopaedic Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449855/
https://www.ncbi.nlm.nih.gov/pubmed/32904035
http://dx.doi.org/10.4055/cios20021
_version_ 1783574704335880192
author Yang, Jae-Ho
Lee, Byoung-Ho
Eum, Kwang-Sik
Suk, Kyoung-Soo
Park, Jin-Oh
Kim, Hak-Sun
Lee, Hwan-Mo
Moon, Seong-Hwan
author_facet Yang, Jae-Ho
Lee, Byoung-Ho
Eum, Kwang-Sik
Suk, Kyoung-Soo
Park, Jin-Oh
Kim, Hak-Sun
Lee, Hwan-Mo
Moon, Seong-Hwan
author_sort Yang, Jae-Ho
collection PubMed
description BACKGROUND: Limited information is available about the proportion of patients with degenerative lumbar spinal disease (DLSD) who have gastrointestinal (GI) and cardiovascular (CV) risk factors. Many DLSD patients are prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) that are known to carry risks to the GI and CV systems by increasing GI bleeding and thromboembolic events. This study aimed to measure the prevalence of GI and CV risk in patients with DLSD and to ascertain whether the prescription of NSAIDs is in line with current guidelines. METHODS: This study included 153 patients with symptomatic DLSD who were planning to undergo lumbar spinal surgery. The GI profile was checked using the GI Standardized Calculator of Risk for Event system and CV risk was evaluated using the presence of metabolic syndrome. The conformity of the prescription of NSAIDs was investigated according to the recommendations in current guidelines. RESULTS: More than half of the patients (59.5%) had high or very high GI risk, and 66% of the patients were diagnosed with metabolic syndrome, which corresponds with CV risk. The rate of simultaneous GI and CV risk was 40.5% (n = 62 / 153; gastrointestinal Standardized Calculator of Risk for Event, > high and metabolic syndrome, yes). The actual prescription of NSAIDs was not in accordance with current guidelines. CONCLUSIONS: Two out of 3 patients had GI or CV risk factors, and approximately 40% of patients had both. Detailed assessment of GI and CV risk in patients with DLSD by using effective evaluation tools is mandatory for optimal medical treatment.
format Online
Article
Text
id pubmed-7449855
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Orthopaedic Association
record_format MEDLINE/PubMed
spelling pubmed-74498552020-09-03 Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease Yang, Jae-Ho Lee, Byoung-Ho Eum, Kwang-Sik Suk, Kyoung-Soo Park, Jin-Oh Kim, Hak-Sun Lee, Hwan-Mo Moon, Seong-Hwan Clin Orthop Surg Original Article BACKGROUND: Limited information is available about the proportion of patients with degenerative lumbar spinal disease (DLSD) who have gastrointestinal (GI) and cardiovascular (CV) risk factors. Many DLSD patients are prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) that are known to carry risks to the GI and CV systems by increasing GI bleeding and thromboembolic events. This study aimed to measure the prevalence of GI and CV risk in patients with DLSD and to ascertain whether the prescription of NSAIDs is in line with current guidelines. METHODS: This study included 153 patients with symptomatic DLSD who were planning to undergo lumbar spinal surgery. The GI profile was checked using the GI Standardized Calculator of Risk for Event system and CV risk was evaluated using the presence of metabolic syndrome. The conformity of the prescription of NSAIDs was investigated according to the recommendations in current guidelines. RESULTS: More than half of the patients (59.5%) had high or very high GI risk, and 66% of the patients were diagnosed with metabolic syndrome, which corresponds with CV risk. The rate of simultaneous GI and CV risk was 40.5% (n = 62 / 153; gastrointestinal Standardized Calculator of Risk for Event, > high and metabolic syndrome, yes). The actual prescription of NSAIDs was not in accordance with current guidelines. CONCLUSIONS: Two out of 3 patients had GI or CV risk factors, and approximately 40% of patients had both. Detailed assessment of GI and CV risk in patients with DLSD by using effective evaluation tools is mandatory for optimal medical treatment. The Korean Orthopaedic Association 2020-09 2020-08-19 /pmc/articles/PMC7449855/ /pubmed/32904035 http://dx.doi.org/10.4055/cios20021 Text en Copyright © 2020 by The Korean Orthopaedic Association http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yang, Jae-Ho
Lee, Byoung-Ho
Eum, Kwang-Sik
Suk, Kyoung-Soo
Park, Jin-Oh
Kim, Hak-Sun
Lee, Hwan-Mo
Moon, Seong-Hwan
Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease
title Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease
title_full Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease
title_fullStr Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease
title_full_unstemmed Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease
title_short Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease
title_sort prevalence of gastrointestinal and cardiovascular risk in patients with degenerative lumbar spinal disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449855/
https://www.ncbi.nlm.nih.gov/pubmed/32904035
http://dx.doi.org/10.4055/cios20021
work_keys_str_mv AT yangjaeho prevalenceofgastrointestinalandcardiovascularriskinpatientswithdegenerativelumbarspinaldisease
AT leebyoungho prevalenceofgastrointestinalandcardiovascularriskinpatientswithdegenerativelumbarspinaldisease
AT eumkwangsik prevalenceofgastrointestinalandcardiovascularriskinpatientswithdegenerativelumbarspinaldisease
AT sukkyoungsoo prevalenceofgastrointestinalandcardiovascularriskinpatientswithdegenerativelumbarspinaldisease
AT parkjinoh prevalenceofgastrointestinalandcardiovascularriskinpatientswithdegenerativelumbarspinaldisease
AT kimhaksun prevalenceofgastrointestinalandcardiovascularriskinpatientswithdegenerativelumbarspinaldisease
AT leehwanmo prevalenceofgastrointestinalandcardiovascularriskinpatientswithdegenerativelumbarspinaldisease
AT moonseonghwan prevalenceofgastrointestinalandcardiovascularriskinpatientswithdegenerativelumbarspinaldisease